Private company
BioCrude Technologies USA, Inc.
BioCrude Technologies USA, Inc. is an American refuse systems company based in Montreal, incorporated in Nevada.2
Last updated Oct 21, 2026.
Overview
- IndustryRefuse Systems2
- HeadquartersMontreal, Canada2
- Incorporated inNV3
- Business address1255 Phillips Square, Suite 605, Montreal, A8 H3B 3G53
- Filer categoryNon-accelerated filer, Smaller reporting company3
- Legal formProfit Corporation2
- LEI549300ONKNDZFYFDGU962
- StatusActive2
- LEI statusIssued and current2
- Registered addressc/o SB Business Services, 8142 Sandy Slope Ct, 89113 Las Vegas, United States2
- Registered withBusiness Center (Secretary of State), E0372342015-02
See how the biggest companies compare on our leaderboards
Systems”. In addition to patent applications, the Company will apply for trademark protection where appropriate.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating income | -$274.3K5 | -$283.7K6 | -$427.3K7 | -$177.7K8 | -$240.4K9 | -$277.1K10 | -$194.0K10 | |
| Interest | $15.4K5 | $4.8K6 | $4.1K7 | $3.9K8 | $3.8K9 | $3.6K10 | $3.5K10 | |
| Income tax | $07 | $08 | $09 | $010 | $010 | |||
| Net income | -$289.6K11 | -$288.5K6 | -$431.5K12 | -$181.5K8 | -$244.2K9 | -$280.8K10 | -$197.4K10 | |
| Earnings per share | $0.008 | $0.009 | -$0.0110 | $0.0010 | ||||
| Earnings per share (diluted) | $0.008 | $0.009 | -$0.0110 | $0.0010 | ||||
| Shares (weighted, basic) | 50.7M shares8 | 50.8M shares9 | 50.9M shares10 | 50.7M shares10 | ||||
| Shares (weighted, diluted) | 50.7M shares8 | 50.8M shares9 | 50.9M shares10 | 50.7M shares10 |
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash | $3056 | $110.0K6 | $1.8K6 | $4399 | $08 | $410 | $1.9K10 | |
| Current assets | $1.8K7 | $4.8K8 | $08 | $5.2K10 | $1.9K10 | |||
| Property, plant and equipment | $20.9K7 | $17.9K8 | $15.9K9 | $13.9K10 | $9.0K10 | |||
| Total assets | $24.1K5 | $129.7K6 | $22.6K7 | $22.7K8 | $15.9K9 | $19.1K10 | $11.0K10 | |
| Short-term debt | $113.1K7 | $126.0K8 | $134.0K9 | $130.6K10 | $137.2K10 | |||
| Current liabilities | $196.5K7 | $173.1K8 | $254.0K9 | $322.1K10 | $482.4K10 | |||
| Long-term debt | $91.6K7 | $101.4K7 | ||||||
| Total liabilities | $384.2K5 | $278.3K6 | $196.5K7 | $173.1K8 | $254.0K9 | $322.1K10 | $482.4K10 | |
| Retained earnings | -$8.8M7 | -$9.0M8 | -$9.2M9 | -$9.5M10 | -$9.7M10 | |||
| Shareholders’ equity | -$358.5K5 | -$147.0K5 | -$171.3K7 | -$147.0K8 | -$234.1K9 | -$299.0K10 | -$467.5K10 | |
| Shares outstanding | 50.5M shares15 | 50.6M shares5 | 50.7M shares6 | 50.8M shares8 | 50.8M shares9 | 50.9M shares10 | 50.9M shares10 | 50.9M shares10 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -$90.2K5 | -$279.6K6 | -$310.3K7 | -$158.2K8 | -$164.1K9 | -$203.7K10 | -$161.4K10 | |
| Capital spending | $5.1K7 | $1.1K8 | $2.2K9 | $2.5K9 | ||||
| Free cash flow | -$315.4K | -$159.3K | -$166.4K | -$206.3K | ||||
| Cash from investing | -$5.1K7 | -$1.1K8 | -$2.2K9 | -$2.5K10 | ||||
| Cash from financing | $207.2K7 | $158.0K8 | $165.9K9 | $206.3K10 | $163.3K10 |
Compare BioCrude Technologies USA, Inc. with another company
What it owns
What BioCrude Technologies USA, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $37.4K10 Dec 31, 2025 | $37.4K10 Dec 31, 2024 | 0% |
| Accumulated depreciation | $28.3K10 Dec 31, 2025 | $23.5K10 Dec 31, 2024 | +20.7% |
| Property and equipment, net | $9.0K10 Dec 31, 2025 | $13.9K10 Dec 31, 2024 | −34.9% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Stakes in other companies (equity method) | $15.0K10 Dec 31, 2025 |
Properties, in its own words
We currently utilize office space at 1255 Phillips Square, Suite 605, Montreal, Quebec, CA H3B 3G5 as our principal offices at no cost to us. We believe these facilities are in good condition, but that we may need to expand our office space as our business efforts increase.
Item 2 of the 10-K filed Mar 27, 2026.4
Timeline
Filings
22 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 2 major events. The latest 20:
- Aug 11, 202610-Q EDGAR
- May 13, 202610-Q EDGAR
- Mar 27, 202610-K EDGAR
- Feb 5, 20268-K EDGAR
- Nov 12, 202510-Q EDGAR
- Aug 13, 202510-Q EDGAR
- May 14, 202510-Q EDGAR
- Mar 27, 202510-K EDGAR
- Nov 7, 202410-Q EDGAR
- Aug 9, 202410-Q EDGAR
- May 8, 202410-Q EDGAR
- Mar 27, 202410-K EDGAR
- Nov 13, 202310-Q EDGAR
- Aug 11, 202310-Q EDGAR
- May 11, 202310-Q EDGAR
- Mar 29, 202310-K EDGAR
- Jan 30, 20238-K EDGAR
- Nov 4, 202210-Q EDGAR
- Aug 10, 202210-Q EDGAR
- May 10, 202210-Q EDGAR
The 22 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How BioCrude Technologies USA, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARBioCrude Technologies USA, Inc.1
- CIK0001690384
- Employer ID (EIN)81-29241604
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company4
- Incorporated inNevada4
- Fiscal year endsDecember 311
- Industry code (SIC)4953 Refuse Systems1
- SEC reviewing officeOffice of Energy & Transportation, Division of Corporation Finance1
- Business address1255 Phillips Square, Suite 605, Montreal, A8 H3B 3G51
- Phone514-962-00701
- Shares outstanding50,876,159 as of Aug 11, 202614
- Public float$0 as of Jun 30, 202510
- AuditorBodwell Vasek Wells DeSimone LLP, Dallas, Texas PCAOB ID 70044
- On EDGAR sinceDec 1, 20161
- Filings68 in all: 10-Q (28), 10-K (9), 8-K (6), S-1/A (5), UPLOAD (5), CORRESP (4), 10-K/A (2), 424B3 (2)1
All 14 form types
NT 10-Q (2), 8-A12G (1), D (1), EFFECT (1), NT 10-K (1), S-1 (1)
- Latest filingsAnnual report (10-K) Mar 27, 2026
Quarterly report (10-Q) Aug 11, 2026
Latest 8-K (8-K) Feb 5, 2026
Risk factors and legal proceedings
The risks BioCrude Technologies USA, Inc. names in Item 1A of its 10-K filed Mar 27, 2026: 7 risks under these headings, as written.4
- We are at a very early operational stage, and our success is subject to substantial risks. An investment in our common stock involves a high degree of risk. You should carefully consider the risks described herein.
- We have a very limited operating history, and our business plan is unproven and may not be successful.
- There are substantial doubts about our ability to continue as a going concern and if we are unable to continue our business, our shares may have little or no value.
- Failure to effectively manage our growth could place strains on our managerial, operational and financial resources and could adversely affect our business and operating results.
- Competition in the Waste Management industry/milieu is highly competitive and there is no assurance that we will be successful in acquiring viable Concession engagements from regulating governmental authorities.
- Risk relating to intellectual property and know-how protection.
- Current and future governmental and environmental regulations could adversely affect our business.
Legal proceedings
From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are not presently a party to any material litigation, nor to the knowledge of management is any litigation threatened against us, which may materially affect us.
The opening of Item 3, Legal Proceedings.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16SEC EDGARChange of auditor
- 17SEC EDGARChange of auditor